NCT06594601 PEEP Titration and Lung Recruitment Potential Assessed by 3D EIT
| NCT ID | NCT06594601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | ARDS |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In a population of ARDS patients, we explore the influence of different PEEP levels on regional ventilation distribution, ventilation homogeneity, and the center of ventilation, optimal PEEP and lung recruitment potential as well as the extent of lung collapse and overdistension as detected by 3D-EIT.
Eligibility Criteria
Inclusion Criteria: * patients on mechanical ventilation. * Diagnosis of ARDS was based on the Berlin definition * lung recruitment potential assessment and PEEP titration was proper for the ARDS patients determined by the attending doctor Exclusion Criteria: * Under 18 years of age. * Pregnant women; * Ribcage malformation * Any contraindication to the use of EIT (e.g. automatic implantable cardioverter defibrillator, and implantable pumps). * Hemodynamic instability, unable to tolerate high PEEP; * High-risk individuals with pneumothorax, mediastinal emphysema, etc.
Contact & Investigator
Huaiwu He, PhD
PRINCIPAL INVESTIGATOR
Department of Critical Care Medicine, Peking Union Medical College, Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT06594601 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ARDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06594601 currently recruiting?
Yes, NCT06594601 is actively recruiting participants. Contact the research team at tjmuhhw@163.com for enrollment information.
Where is the NCT06594601 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06594601 clinical trial?
NCT06594601 is sponsored by Peking Union Medical College Hospital. The principal investigator is Huaiwu He, PhD at Department of Critical Care Medicine, Peking Union Medical College, Peking Union Medical College Hospital. The trial plans to enroll 50 participants.